Endo Labs Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 3.35 Cr
as on 16-12-2024
- Company Age 30 Year, 5 Months
- Last Filing with ROC 31 Mar 2011
- Open Charges ₹ 15.00 Cr
as on 16-12-2024
- Satisfied Charges ₹ 13.20 Cr
as on 16-12-2024
About Endo Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2011. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.35 Cr.
The company currently has active open charges totaling ₹15.00 Cr. The company has closed loans amounting to ₹13.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ramesh Lulla, Nitin Kingrani, Shailendra Agrawal, and Two other members serve as directors at the Company.
- CIN/LLPIN
L24232MP1994PLC008476
- Company No.
008476
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Jul 1994
- Date of AGM
30 Sep 2011
- Date of Balance Sheet
31 Mar 2011
- Listing Status
Listed
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Endo Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Lulla  | Managing Director | 18-Jul-1994 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nitin Kingrani | Director | 25-Aug-2004 | Current |
| Shailendra Agrawal | Whole-Time Director | 01-Apr-2008 | Current |
| Sidharth Lulla | Whole-Time Director | 30-Sep-2008 | Current |
| Dheeraj Lulla | Whole-Time Director | 15-Apr-1995 | Current |
Financial Performance and Corporate Structure Insights of Endo Labs.
Enhance accessibility to Endo Labs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Endo Labs?
Unlock access to Endo Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 21 Oct 2011 | ₹15.00 Cr | Open |
State Bank Of Indore Creation Date: 11 Oct 2005 | ₹13.20 Cr | Satisfied |
State Bank Of Indore Creation Date: 14 Oct 2004 | - | Satisfied |
How Many Employees Work at Endo Labs?
Endo Labs has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Endo Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Endo Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
